PlexZyme

Single biomarker detection kits providing high-quality results at low cost. Complement multiplex arrays for targeted biomarker analysis in research applications.

Verified, pre-configured, and ready-to-use multiplex arrays designed for rapid, sensitive, and convenient biological measurements. These assays enable researchers to measure multiple analytes simultaneously in a single sample.

Q-Plex Singleplex assays are used to detect and quantify a wide range of biomarkers, measuring between 1 and 18 biomarkers in a well. These assays utilize traditional ELISA protocol and can accommodate up to 40 duplicate samples. The assays provide accurate, consistent, and reliable results with increased sensitivity, and use the same antibody pairs as multiplex assays to ensure direct comparability of data between assays. Available variants: Q-Plex™ Singleplex Assays.

Personalized multiplex assay panels customized to specific research requirements. These assays are developed using Q-Plex™ approved reagents to deliver optimized performance for individual applications.

Molecular diagnostic products for infectious disease detection and identification. These multiplexed assays enable rapid and accurate pathogen identification in clinical samples.

Ready-to-use multiplex microplate kits that detect up to 18 biomarkers simultaneously for research applications. Available in pre-configured formats or customizable panels across human, mouse, and other species for disease understanding and biomarker analysis.

A point-of-care molecular testing system built on FlashDx's proprietary semi-Solid Phase Real Time PCR (SPRT™) technology. The system delivers simple, fast, and comprehensive multiplexed molecular test results within one hour. It is designed for near-patient syndromic testing with a growing test menu and potential expansion to oncology and other disease areas.

An advanced molecular diagnostic test for detailed identification and characterization of multidrug-resistant bacteria.

Multiplex precision oncology assay platform with ready-to-use kits and automated analysis for high-throughput testing. Integrates seamlessly into existing laboratory infrastructure for scalable hematologic malignancy and liquid biopsy detection.

A multiplexed molecular point-of-care system built on FlashDx's proprietary semi-Solid Phase Real Time PCR (SPRT™) technology. The system delivers simple, fast and comprehensive results within one hour. It is designed for near-patient syndromic testing solutions and provides fast and accurate multiplexed molecular tests for use anywhere.

A comprehensive molecular diagnostic test for the detection of multidrug-resistant bacteria and resistance mechanisms.

A proprietary platform enabling comprehensive multi-biomarker testing in one integrated workflow. Designed for robust molecular precision diagnostics in oncology and clinical research.